Company: DMAAR
Filing Date: 2025-01-14
Form Type: POS AM
Source: 0001213900-25-003137
Chunk: 137

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-01-14
Form: POS AM
Chunk 137
---
  (5,483,159 | ) |
| Total capitalization                                                                                                                                                                                                                                   |     | $                  |  387,156 |   |     | $           | 201,935,141 |   |

____________ (1)Our sponsor has agreed to loan us up to $1,850,000 under an unsecured promissory note to be used for a portion of the expenses of this offering and to finance transaction costs in connection with an intended initial business combination. The “as adjusted” information gives effect to the repayment of any loans made under this note out of the proceeds from this offering. As of September 30, 2024, we have borrowed $552,015 under the promissory note. (2)Assumes the full surrender and forfeiture of 1,285,714shares that are subject to surrender and forfeiture by our initial shareholders depending on the extent to which the underwriters’ over -allotmentoption is exercised. The proceeds of the sale of such shares will not be deposited into the trust account, the shares will not be eligible for redemption from the trust account nor will they be eligible to vote upon the initial business combination. (3)Upon the completion of our initial business combination, we will provide our public shareholders with the opportunity to redeem their public shares for cash equal to their pro rata share of the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest (net of funds withdrawn to pay our taxes, if any), following such redemptions, and any limitations (including, but not limited to, cash requirements) created by the terms of the proposed business combination. All ordinary shares are redeemable and classified as such on the balance sheet until such date that a redemption event takes place. All of the 20,000,000 ordinary shares sold as part of the units in the offering contain a redemption feature which allows for the redemption of such public shares in connection with our liquidation, if there is a shareholder vote or tender offer in connection with the business combination and in connection with certain amendments to our amended and restated memorandum and articles of association. The “as adjusted” amount of ordinary shares subject to redemption equals the “as adjusted” total assets of $201,935,141 less the “as adjusted” total liabilities of $6,418,300 less “as adjusted” total shareholders’ deficit of $5,483,159. The value of ordinary shares that may be redeemed